valsartan

Known as: N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine, (S)-N-Valeryl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]-methyl}-valine, N-valeryl-N-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)valine 
An orally active nonpeptide triazole-derived antagonist of angiotensin (AT) II with antihypertensive properties. Valsartan selectively and… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2007
Highly Cited
2007
BACKGROUND The aim of this study was to assess dual renin system intervention with the maximum recommended doses of aliskiren and… (More)
Is this relevant?
Highly Cited
2007
Highly Cited
2007
Recent epidemiological evidence suggests that some antihypertensive medications may reduce the risk for Alzheimer disease (AD… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2005
Highly Cited
2005
BACKGROUND The role of C-reactive protein (CRP) in heart failure is not well studied. We assessed the prognostic value of CRP in… (More)
  • table 1
  • figure 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
Highly Cited
2003
Highly Cited
2003
BACKGROUND Angiotensin-converting-enzyme (ACE) inhibitors such as captopril reduce mortality and cardiovascular morbidity among… (More)
  • table 1
  • table 1
  • figure 1
  • table 2
  • figure 3
Is this relevant?
Highly Cited
2003
Highly Cited
2003
BACKGROUND Neurohormones are considered markers of heart failure progression. We examined whether changes in brain natriuretic… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2002
Highly Cited
2002
BACKGROUND Elevated urine albumin excretion (UAER) is a modifiable risk factor for renal and cardiovascular disease in type 2… (More)
  • table 1
  • table 2
  • figure 2
  • figure 1
  • table 3
Is this relevant?
Highly Cited
2002
Highly Cited
2002
BACKGROUND Brain natriuretic peptide (BNP) and norepinephrine (NE) are strongly related to severity of and are independent… (More)
  • figure 1
  • figure 3
  • figure 2
Is this relevant?
Highly Cited
2002
Highly Cited
2002
OBJECTIVES A subgroup analysis of the Valsartan Heart Failure Trial (Val-HeFT) was performed to evaluate the effects of the… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2001
Highly Cited
2001
BACKGROUND Actions of angiotensin II may contribute to the progression of heart failure despite treatment with currently… (More)
Is this relevant?